BioCardia, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
BioCardia, Inc. (BCDA) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $5.20 million as of 2019-03-31, per its 10-Q filed 2019-05-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2019-05-15
- 2019-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $5.20M.
- 2018-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $5.60M.
- 2018-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $6.30M.
- 2018-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $6.70M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2019-03-31 | $5.20M 10-Q · filed 2019-05-15 |
| 2018-09-30 | $5.60M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $6.30M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $6.70M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $4.90M 10-K · filed 2018-03-16 |
| 2017-09-30 | $4.70M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $4.40M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $4.10M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $2.80M 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |